Clinical Trial Update: Therascreen® KRAS RGQ PCR Kit [NA]

View source ↗

Summary

Clinical trial update indicates the Therascreen KRAS RGQ PCR Kit by QIAGEN for colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Therascreen KRAS RGQ PCR Kit (KRAS RGQ PCR Kit)

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Colo-rectal Cancer | NA | Status: COMPLETED